Serodus ApS Appoints New Chief Executive Officer to Lead Strategic Divestment of Assets
Copenhagen — September 17, 2026 — Serodus ApS, a biotechnology company focused on the development of innovative anti-inflammatory compounds, today announced the appointment of Lars Smedegaard Andersen as Chief Executive Officer, effective as of today.